Provided by Tiger Fintech (Singapore) Pte. Ltd.

Valneva SE

6.35
-0.1050-1.63%
Volume:14.90K
Turnover:95.95K
Market Cap:530.27M
PE:-36.46
High:6.49
Open:6.44
Low:6.17
Close:6.45
Loading ...

Valneva Is Maintained at Buy by Guggenheim

Dow Jones
·
24 Mar

Stock Track | Valneva Soars 7.25% Pre-market on Chikungunya Vaccine Supply for La Réunion Outbreak

Stock Track
·
24 Mar

Stock Track | Valneva SE Surges 7.25% Pre-market on Chikungunya Vaccine Supply for La Réunion Outbreak

Stock Track
·
24 Mar

Valneva Se : Guggenheim Cuts Target Price to $15 From $17

THOMSON REUTERS
·
24 Mar

Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion

GlobeNewswire
·
24 Mar

Valneva Price Target Maintained With a $17.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Mar

Valneva SE (INRLF) (FY 2024) Earnings Call Highlights: Strong Sales Growth and Strategic ...

GuruFocus.com
·
21 Mar

Valneva SE reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
20 Mar

Stock Track | Valneva Soars 11.29% Pre-Market on Strong 2024 Results and Positive 2025 Outlook

Stock Track
·
20 Mar

Pharming For 2025 Expects Product Sales Of €170M–180M And Total Revenues Of €180M–190M; Sees R&D Investments Of €90M–100M

Benzinga
·
20 Mar

Valneva FY Sales €169.60M Up From €153.7M YoY, Net Loss €12.2M Compared To Net Loss €101.4M YoY

Benzinga
·
20 Mar

Press Release: Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook

Dow Jones
·
20 Mar

High Growth Tech Stocks In Europe For March 2025

Simply Wall St.
·
10 Mar

VALNEVA Declaration of shares and voting rights: February 28, 2025

GlobeNewswire
·
06 Mar

Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences

GlobeNewswire
·
03 Mar

Valneva reports positive CHMP opinion for adolescent label extension for Ixchiq

TIPRANKS
·
01 Mar

Valneva Receives EMA’s Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®

GlobeNewswire
·
01 Mar

Valneva Price Target Maintained With a $17.00/Share by HC Wainwright & Co.

Dow Jones
·
01 Mar

Analysts Offer Insights on Healthcare Companies: Valneva (VALN) and Butterfly Network (BFLY)

TIPRANKS
·
28 Feb

Valneva Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
19 Feb